Dermatology

  • Acne Vulgaris
  • Actinic Keratosis
  • Aesthetic Dermal Filler
  • Alopecia
  • Atopic Dermatitis
  • Basal Cell Carcinoma
  • Cellulite
  • Dercum’s Disease
  • Genital Warts
  • Healthy Volunteers
  • Head Lice
  • Herpetic Injections
  • Keloid Scar
  • Melasma
  • Onychomycosis
  • Photodamage, including Lentigines
  • Psoriasis
  • Plaque Psoriasis
  • Rosacea
  • Scalp Psoriasis
  • SunScreen
  • Venous Leg & Diabetic Foot Ulcers
  • Tinea Pedis & Corporis

Integrium’s Dermatology Clinical Trial Experience

* Over 100 dermatologic studies completed
* 45 Phase I HPA, irritation & sensitization, bioavailability, QTc, and safety studies for topical, systemic, and aesthetic therapies

Largest Trial by Indication – 150+ Trials
Study Phase Indication # Patients # Sites Location
III Diabetic Foot Ulcer 1,000 91 N. America
III Diabetic Foot Ulcer 400 37 N. America
II Papulopastular Rosacea 240 15 N. America
I, III Actinic Keratosis 240 20 N. America
IIb Venous Leg Ulcer 120 8 N. America and S. Africa
I – IV Acne Vulgaris 160 5 N. America
I Plaque Psoriasis 34 1 N. America, Europe
III – IV Scalp Psoriasis 30 1 N. America
III Aesthetic Dermal Filler 30 1 N. America
III Alopecia 30 1 N. America
IB – IV Atopic Dermatitis 30 1 N. America, Australia, Europe, S. Africa
III Basal Cell Carcinoma 30 1 N. America
III Genital Warts 30 1 N. America
III Head Lice 30 1 N. America
III Herpetic Infections 30 1 N. America
III Melasma 30 1 N. America
II – IV Onychomycosis 30 1 N. America, Europe
III Photodamage, including lentigines 30 1 N. America
I – III Sun Screen 30 1 N. America
III Tinea Pedis & Corporis 30 1 N. America